Skip to main content

Table 3 The panel of targeted drugs classified according to their therapeutic targets, primary effector pathways, or signaling pathway; and the sensitivity for each malignant cell lines

From: Optimization of combination chemotherapy based on the calculation of network entropy for protein-protein interactions in breast cancer cell lines

Drugs group

HSP90*

PI3K-AKT¥

mTOR†

Angiog.

EGFR Retal

MT/Cyts**

RasRaf***

Cell cycle

HDAC

Average

Targets

I

II††

III‡‡

IV₤₤

Va

VIb

VIIc

VIIId

IXe

 

Lf

          

MCF-7

6.43

5.92

6.32

4.47

4.65

7.27

4.99

5.57

5.54

5.69

T-47D

NA

6.21

6.08

4.56

4.62

6.33

4.63

5.49

5.57

5.44

ZR-75-1

6.74

5.66

4.18

4.41

4.57

6.91

4.95

5.13

5.22

5.31

BT-474

7.77

6.42

7.84

4.58

5.73

6.93

4.55

5.14

5.82

6.09

Correl.g

−0.462

−0.746

−0.953

−0.699

−0.704

−0.327

0.420

−0.222

−0.918

−0.923

TNh

          

BT-20

NA

5.38

6.99

4.47

4.99

7.00

4.81

5.40

5.09

5.52

MDA-MB-231

6.82

5.06

5.45

4.42

4.65

7.70

5.22

5.18

4.68

5.47

MDA-MB-468

6.59

5.70

5.40

4.38

4.90

7.78

4.78

6.31

5.19

5.67

Correl.

1.000

−0.504

0.877

0.998

0.245

−0.905

0.064

−0.764

−0.189

−0.725

Tot. correl.i

−0.391

−0.605

−0.528

−0.411

−0.546

−0.205

0.351

−0.298

−0.588

−0.859

  1. *HSP90: Heat shock protein 90; ¥PI3K-AKT: Phosphatidylinositol 3′ -kinase(PI3K)-Akt signaling pathway; mTOR: Mammalian target of rapamycin; Angiog.: Angiogenesis ; ₤EGFR Retal: EGFR/FGFR/HER2/IGFR pathway; **MT/Cyt: microtubule/cytoskeleton; ***RasRaf: Ras-Raf-MEK-MAPK-ERK pathway; Cell cycle: cell cycle involved proteins ; HDAC: histone deacetylases; I: HSP90AA1; ††II: AKT, AKT1, AKT2, PIK3CA, PIK3CB, PIK3CD, PIK3CG, ZNF217; ‡‡III: mTOR; ₤₤IV: MMP2, MMP9, VEGFR2
  2. aV: EGFR, ERBB2, ESR1, FGFR3, IGF1R
  3. bVI: BCL2, CENPE, Kinesin, ROCK2, TUBB, TUBB1, TUBB3
  4. cVII: BRAF, ELK3, MAP2K1, MAP2K2, MAPK9, MAPK10
  5. dVIII: AURKA, AURKB, AURKC, CCNB1, CDC25A, CDC25B, CDC25C, CDK1, CDK4, CHEK1, NAE1, PLK1, polyamine analogue
  6. eIX:HDAC
  7. fL: Luminal
  8. gCorrelation of drug GI50 with entropy per node (see Table 1)
  9. hTN: Triple-negative
  10. iTot. correl: correlation for L and TN together